DISC1 and schizophrenia: In DISC1 loss of function mice displaying schizophrenia-like behavior, disruption of GSK-3-DISC1 interactions, or treatment with SB-216763, reduced hyper-locomotion and produced anti-depressive like activity in FST (Mao et al., 2009).